Long-term Results of Multimodal Therapy for Chronic Prostatitis/chronic Pelvic Pain Syndrome

Header Cap

Purpose: Chronic prostatitis/chronic pelvic pain syndrome is a prevalent and multifactorial condition. Many patients have the condition for years despite conventional therapies. We assess the outcomes of multimodal therapy in patients with long-standing chronic prostatitis/chronic pelvic pain syndrome.

Materials and Methods: A total of 53 patients with chronic prostatitis treated at our clinic with a minimum followup of 6 months were assessed by the National Institutes of Health-Chronic Prostatitis Symptom Index and by a global assessment score. Treatments included antibiotics, prostatic massage, anti-inflammatory phytotherapy, [alpha]-blockers and neuromuscular agents.

Results: Mean age patient was 45 years and median symptom history was 3.5 years. Based on localizing cultures, and microscopy of urine and prostatic fluid 13% of the cases were category II, 41% were category IIIa and 46% were category IIIb. Mean followup from the last visit was 417 days (range 185 to 1,247). Mean changes +/- SE from the initial to the final score on the National Institutes of Health-Chronic Prostatitis Symptom Index were 10.4 +/- 3.3 to 5.9 +/- 4.4 for pain, 4.2 +/- 2.9 to 2.0 +/- 2.7 for urinary, 8.2 +/- 2.9 to 4.7 +/- 3.4 for quality of life and 22.7 +/- 6.6 to 13.2 +/- 9.5 for total score (p < 0.0001). Based on a global subjective assessment 43 of the patients (80%) were better, 8 were the same and 3 were worse. At final assessment 39% of the patients were on no therapy, 22% were on an [alpha]-blocker, 37% were on quercetin, 13% were on neuromuscular agents and 9% were on antibiotics.

Conclusions: An approach using stepwise therapy with antibiotics, anti-inflammatories and neuromuscular agents can be successful in the majority of patients with long-standing chronic prostatitis.

Participants: SHOSKES, DANIEL A. *; HAKIM, LAWRENCE +; GHONIEM, GAMAL ++; JACKSON, CHARLES L.

Journal of Urology. 169(4):1406-1410, April 2003.

PROSTA Q COMPLEX

60 545mg capsules (30-day supply)

Clinically proven Prosta-Q is a specially formulated blend of bioflavonoids shown to have antioxidant, anti-inflammatory, and anti-microbial effects.

$39.99

 

 

3 MONTHS SUPPLY OF PROSTA Q COMPLEX

180 545mg capsules (90-day supply)

Clinically proven Prosta Q is a specially formulated blend of bioflavOnoids shown to have antioxidant, anti-inflamMatory, and anti-microbial effects.

$99.99

 

 

Q-UROL COMPLEX

60 900mg tablets (30-day supply)

Q-Urol contains all the same ingredients as Prosta-Q plus Bee Pollen and Pumpkin Seed in a higher potency time-release formula.

$59.99

 

 

 

The statements contained in this site have not been evaluated by the FDA. The products detailed on this site are not meant to diagnose, treat, cure or prevent any disease. If a medical condition exists, see your health care professional.

© Farr Laboratories 2008 -- ph: 877-284-3976

Evidence-based nutraceutical for maintaining prostate, bladder and colon health